Total Assets
West Pharmaceutical Services Total Assets decreased by 3.8% to $4.11B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 13.6%, from $3.62B to $4.11B. Over 5 years (FY 2020 to FY 2025), Total Assets shows an upward trend with a 8.9% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
Growth generally indicates business expansion, while a decline may suggest asset liquidation or a contraction in business scale.
Detailed definition
This is the sum of all current and non-current assets owned by the company, representing the total resource base availab...
Peer comparison
Universal financial metric used by all public companies to define the size of the balance sheet.
total_assetsHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.93B | $3.14B | $3.31B | $3.29B | $3.36B | $3.32B | $3.62B | $3.72B | $3.67B | $3.75B | $3.83B | $3.60B | $3.49B | $3.68B | $3.64B | $3.62B | $3.95B | $4.11B | $4.27B | $4.11B |
| QoQ Change | — | +7.1% | +5.4% | -0.6% | +2.0% | -1.3% | +9.0% | +3.0% | -1.5% | +2.3% | +2.0% | -5.9% | -3.1% | +5.3% | -0.9% | -0.7% | +9.2% | +3.9% | +4.0% | -3.8% |
| YoY Change | — | — | — | — | +14.6% | +5.5% | +9.1% | +13.0% | +9.2% | +13.2% | +5.9% | -3.3% | -4.9% | -2.1% | -4.9% | +0.4% | +13.3% | +11.7% | +17.2% | +13.6% |
Business Segments
| Segment | Q4 '22 | Q4 '23 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Proprietary Products | $2.58B | $2.63B | $2.62B | $2.63B | $2.83B | $2.99B | $2.99B | $2.93B |
| West Vantage | — | — | — | — | — | — | — | $739.60M |
| Contract-Manufactured Products | $480.30M | $527.50M | $612.20M | $627.70M | $667.90M | $685.90M | $718.10M | — |
| Total | $3.62B | $3.83B | $3.64B | $3.62B | $3.95B | $4.11B | $4.27B | $4.11B |
Contract-Manufactured Products was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.
Total Assets at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's total assets?
- West Pharmaceutical Services (WST) reported total assets of $4.11B in Q1 2026.
- How has West Pharmaceutical Services's total assets changed year-over-year?
- West Pharmaceutical Services's total assets increased by 13.6% year-over-year, from $3.62B to $4.11B.
- What is the long-term trend for West Pharmaceutical Services's total assets?
- Over 5 years (2020 to 2025), West Pharmaceutical Services's total assets has grown at a 8.9% compound annual growth rate (CAGR), from $2.79B to $4.27B.
- What does total assets mean?
- The total value of everything the company owns.